Etesian Wealth Advisors Inc. Trims Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Etesian Wealth Advisors Inc. trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 896 shares of the healthcare conglomerate’s stock after selling 84 shares during the period. Etesian Wealth Advisors Inc.’s holdings in UnitedHealth Group were worth $443,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Texas Capital Bancshares Inc TX raised its holdings in shares of UnitedHealth Group by 1.1% in the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after purchasing an additional 19 shares in the last quarter. Tealwood Asset Management Inc. boosted its position in shares of UnitedHealth Group by 0.4% in the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after purchasing an additional 19 shares during the period. Atlas Private Wealth Advisors boosted its holdings in shares of UnitedHealth Group by 1.1% in the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock worth $923,000 after buying an additional 19 shares during the period. Prentice Wealth Management LLC lifted its position in shares of UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock valued at $1,235,000 after acquiring an additional 19 shares in the last quarter. Finally, Baker Avenue Asset Management LP grew its position in UnitedHealth Group by 1.7% during the 3rd quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock worth $615,000 after purchasing an additional 20 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 0.5 %

Shares of NYSE:UNH traded up $2.53 during trading on Wednesday, hitting $487.03. 1,502,176 shares of the company’s stock were exchanged, compared to its average volume of 4,145,494. The firm has a market cap of $448.26 billion, a P/E ratio of 29.56, a PEG ratio of 1.41 and a beta of 0.58. The firm has a 50-day moving average price of $498.20 and a two-hundred day moving average price of $502.75. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.26 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were given a dividend of $2.10 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a yield of 1.72%. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s dividend payout ratio is 51.34%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on UNH. Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Truist Financial restated a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Finally, TD Cowen dropped their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.